USC Norris Comprehensive Cancer Center

Leadership

Senior Leadership

Screen Shot 2020-11-03 at 2.44.23 PM

Caryn Lerman, PhD

Director, USC Norris Comprehensive Cancer Center

Lourdes Baezconde-Garbanati earns AACR Distinguished Lectureship

Lourdes Baezconde-Garbanati, MPH, PhD

Associate Director,
Community Outreach & Engagement

John Carpten, PhD

Associate Director, Basic Research

Amir

Amir Goldkorn, MD

Associate Director, Translational Research

Lenz 3

Heinz-Josef Lenz, MD

Associate Director, Clinical Research

Stern

Mariana Stern, PhD

Associate Director, Population Science

Alan S. Wayne, MD

Associate Director, Pediatric Oncology

David Conti, PhD

Associate Director, Data Science

Yves DeClerck, MD

Associate Director, Cancer Research Training and Education

Chanita

Chanita Hughes-Halbert, PhD

Associate Director, Cancer Equity

Amy S. Lee, PhD

Associate Director, Shared Resources

Anthony

Anthony B. El-Khoueiry, MD

Director, Clinical Investigations Support Office

Chris

Christopher Loertscher, MA

Associate Director for Administration & Chief Administrative Officer

grossman news

Steven Grossman, MD, PhD

Deputy Director for Cancer Services

Anest

Vasiliki Anest, PhD

Chief Innovation Officer

Program Leaders

Genomic and Epigenomic Regulation

The program is led by Bodour Salhia, PhD, a translational genomics scientist with extensive knowledge and expertise in mechanisms that underlie tumorigenesis and tumor biology, and Yali Dou, PhD, known for translation of epigenetic discoveries into novel inhibitors.

Yali Dou

Yali Dou, PhD

Co-Leader

Tumor Microenvironment

The program co-leaders, W. Martin Kast, PhD, and Rongfu Wang, PhD, have complementary recognized expertise in cancer virology & cancer immunology and in immunotherapy, innate immune signaling & epigenetic programming, respectively.

Translational and Clinical Sciences

The program co-leaders, John Carpten, PhD, Parkash Gill, MD, and Heinz-Josef Lenz, MD, have complementary recognized expertise in cancer genomics, drug target discovery, drug development, and translational research and clinical trials.

Cancer Epidemiology

The program co-leaders, Wendy Setiawan, PhD, and Christopher Haiman, ScD, have complementary recognized expertise in cancer epidemiology and genetics, and immunology, biomarkers and biobanking, respectively.

Cancer Control Research

The program co-leaders, Myles Cockburn, PhD, and Jennifer Unger, PhD, have complementary recognized expertise in cancer prevention and cancer survivorship.